Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Fatty Acid Oxidation Disorders (FAODs) Market Covering 2025–2034?
The fatty acid oxidation disorders (faods) market has seen substantial growth in recent years. It is anticipated to increase from $9.55 billion in 2024 to $10.23 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.2%. This historical growth can be linked to heightened awareness, an uptick in the prevalence of rare and genetic disorders, a rising count of product approvals, amplified government initiatives, and growing demand for orphan drugs.
The market for fatty acid oxidation disorders (FAODs) is projected to experience substantial expansion over the upcoming years, with a forecast to reach a valuation of $13.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.5%. This anticipated growth during the forecast period stems from the rising demand for sustainable bio-products, the wider embrace of personalized medicine, earlier detection of FAODs, increased financial investment in research and development, and a heightened emphasis on enhancing long-term patient outcomes. Key trends expected in the forecast timeframe encompass the incorporation of telehealth services, the application of artificial intelligence in diagnostics and the development of new drugs, progress in genetic testing, technological improvements, and a movement towards healthcare models centered on the patient.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21964&type=smp
What Are The Top Growth Drivers Impacting The Fatty Acid Oxidation Disorders (FAODs) Market Outlook?
The fatty acid oxidation disorders (FAODs) market is projected to grow, driven by the increasing demand for gene therapy, a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The heightened interest in gene therapy stems from its capability to address genetic conditions, cancer, and rare ailments by pinpointing their fundamental genetic origins, thereby attracting substantial funding and fostering progress in biotechnology. For fatty acid oxidation disorders, gene therapy aims to rectify metabolic shortcomings through the introduction of functional genes, thereby re-establishing enzymatic function, boosting energy synthesis, and averting related complications. As an illustration, data from April 2024, provided by the American Society of Gene & Cell Therapy, a US-based organization dedicated to gene and cell therapy, revealed a 10% rise in gene therapies undergoing Phase III clinical trials during the fourth quarter. This represented the initial quarterly expansion of its type since the third quarter of 2022. Consequently, the growing need for gene therapy is serving as a primary catalyst for the expansion of the fatty acid oxidation disorders (FAODs) market.
What Are The Primary Types Of Segments Analyzed In The Fatty Acid Oxidation Disorders (FAODs) Market?
The fatty acid oxidation disorders (faods)market covered in this report is segmented –
1) By Type: Long Chain; Short Chain
2) By Drug Type: Levocarnitine; Dextrose; Riboflavin; Other Drug Types
3) By Route of Administration: Oral; Intravenous
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Online Stores
5) By End User: Hospitals; Clinics; Pharmaceutical Companies
Subsegments:
1) By Long Chain: Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD); Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD); Trifunctional Protein Deficiency (TFP); Carnitine Palmitoyltransferase II Deficiency (CPT II)
2) By Short Chain: Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD); Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD); Carnitine Uptake Defect (CUD)
What Long-Term Trends Will Shape The Future Growth Of The Fatty Acid Oxidation Disorders (FAODs) Industry?
Leading companies in the fatty acid oxidation disorders (FAODs) market are concentrating on developing innovative solutions, such as peroxisome proliferator-activated receptor delta (PPARδ) agonists, to improve metabolic control and enhance treatment outcomes for patients with FAODs. A PPARδ agonist is a substance that activates the PPARδ receptor, which plays a role in regulating lipid metabolism, inflammation, and energy balance, potentially offering therapeutic advantages for metabolic disorders and cardiovascular diseases. For example, in January 2023, Reneo Pharmaceuticals Inc., a US-based clinical-stage pharmaceutical company, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for its investigational drug, Mavodelpar (REN001). This drug targets long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, a genotype associated with long-chain fatty acid oxidation disorder (LC-FAOD). Through the activation of PPARδ, Mavodelpar seeks to enhance mitochondrial function, improve energy metabolism, and alleviate symptoms linked to LC-FAOD.
Who Are The Prominent Global Companies Shaping The Fatty Acid Oxidation Disorders (FAODs) Market?
Major companies operating in the fatty acid oxidation disorders (FAODs) market are BASF SE, Thermo Fisher Scientific Inc, Takeda Pharmaceutical Company Limited, Baxter International Inc, Koninklijke DSM NV, Ingredion Incorporated, Lonza Group Ltd, Roquette Frères SA, Dr Reddy’s Laboratories Limited, Tate & Lyle PLC, ANI Pharmaceuticals Inc, Ultragenyx Pharmaceutical Inc, Gulshan Polyols Limited, Hubei Guangji Pharmaceutical Co Ltd, Omega Laboratories Limited, Actiza Pharmaceutical Private Limited, Allmpus Laboratories Private Limited, Reneo Pharmaceuticals Inc, Greenwell Lifesciences, NB Group Co Ltd.
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Fatty Acid Oxidation Disorders (FAODs) Market?
Asia-Pacific was the largest region in the fatty acid oxidation disorders (FAODs) market in 2024. The regions covered in the fatty acid oxidation disorders (FAODs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Fatty Acid Oxidation Disorders (FAODs) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21964&type=smp
Browse Through More Reports Similar to the Global Fatty Acid Oxidation Disorders (FAODs) Market 2025, By The Business Research Company
Fatty Acids Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fatty-acids-global-market-report
Tall Oil Fatty Acid Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/tall-oil-fatty-acid-global-market-report
Fatty Acids Global Market 2025
https://www.thebusinessresearchcompany.com/report/fatty-acids-global-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model